The human ras proteins are members of a superfamily of low molecular weight GTP-binding proteins. While considerable experimental evidence provides strong support for a role of the ras proteins in malignant transformation, to date, no other member of the ras superfamily has been identified as oncogene proteins. However, recent observations have provided support that members of one branch of ras-related proteins, the rho subfamily (rac1 and 2, rho A,B,C, and G, CDC42Hs, TC10) may contribute to the aberrant growth properties of malignant cells. First, elevated expression of rho proteins has been associated with enhanced cellular proliferation and alterations in cellular morphology. Second, truncated versions of three rho family regulatory proteins (dbl, vav, ect-2) have been identified as potent oncogene proteins. These three proteins are like to function as activators (exchange factors) of rho protein function, and may trigger transformation via chronic activation of rho protein function. Finally, there is evidence that oncogenic ras proteins mediate some aspects of malignant transformation via activation of rho family proteins. Altogether, these observations have prompted our studies to determine if aberrant function of rho family proteins, and of their regulatory proteins, contribute to malignant transformation.
The specific aims of this proposal are (1) to assess the possibility that rho family proteins (racs and rhos) are potential oncogenes, (2) to determine if the full malignant phenotype triggered by oncogenic ras is dependent on rac and rho protein function, and (3) to determine if dbl family oncogenes trigger uncontrolled growth via deregulating rho protein function. The long-range goals of these studies will be to determine if aberrant rho function contributes to the malignant phenotype of human tumor cells and to determine how rho family proteins mediate changes in the actin cytoskeleton, focal adhesion plaques, and extracellular matrix that regulate cell-substratum interactions and cell motility.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA063071-04
Application #
2390807
Study Section
Pathology A Study Section (PTHA)
Project Start
1994-06-01
Project End
1998-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Pharmacology
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Mitin, Natalia; Roberts, Patrick J; Chenette, Emily J et al. (2012) Posttranslational lipid modification of Rho family small GTPases. Methods Mol Biol 827:87-95
Vigil, Dominico; Cherfils, Jacqueline; Rossman, Kent L et al. (2010) Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer 10:842-57
Madigan, James P; Bodemann, Brian O; Brady, Donita C et al. (2009) Regulation of Rnd3 localization and function by protein kinase C alpha-mediated phosphorylation. Biochem J 424:153-61
Roberts, Patrick J; Mitin, Natalia; Keller, Patricia J et al. (2008) Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J Biol Chem 283:25150-63
Kim, Tai Young; Healy, Kevin D; Der, Channing J et al. (2008) Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration. J Biol Chem 283:32762-70
Healy, Kevin D; Hodgson, Louis; Kim, Tai-Young et al. (2008) DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Mol Carcinog 47:326-37
Cha, Jiyoung Y; Lambert, Que T; Reuther, Gary W et al. (2008) Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis. Mol Cancer Res 6:435-45
Onesto, Cercina; Shutes, Adam; Picard, Virginie et al. (2008) Characterization of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. Methods Enzymol 439:111-29
Mitin, Natalia; Betts, Laurie; Yohe, Marielle E et al. (2007) Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression. Nat Struct Mol Biol 14:814-23
Shutes, Adam; Onesto, Cercina; Picard, Virginie et al. (2007) Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. J Biol Chem 282:35666-78

Showing the most recent 10 out of 74 publications